Results for tag: "Tanezumab"

Tanezumab is a monoclonal antibody used as an analgesic for the treatment of chronic pain. It is a type of biologic therapy, which works by blocking nerve growth factor (NGF) to reduce inflammation and pain. Tanezumab is administered as an intravenous infusion and is used to treat osteoarthritis, low back pain, and cancer-related pain. It is also being studied for the treatment of other chronic pain conditions. Tanezumab is a relatively new analgesic, and its use is still being studied. It is generally well-tolerated, with the most common side effects being joint pain, headache, and nausea. It is important to note that tanezumab has been associated with an increased risk of joint destruction and bone loss, so it should be used with caution. Several companies are involved in the tanezumab market, including Pfizer, Eli Lilly, and Regeneron Pharmaceuticals. These companies are researching and developing tanezumab for the treatment of chronic pain. Show Less Read more